How should I manage a male patient with persistent urethritis and possible epididymitis after a previously treated Ureaplasma infection who now has a negative nucleic acid amplification test (NAAT)?

Management of Persistent Urethritis After Treated Ureaplasma Infection

In a patient with persistent symptoms after documented Ureaplasma treatment who now tests negative by NAAT, you should first confirm objective evidence of ongoing urethritis with microscopy before retreating, then test for Mycoplasma genitalium, Trichomonas vaginalis, and consider reinfection or non-infectious causes rather than assuming persistent Ureaplasma infection.

Initial Assessment: Confirm True Urethritis

The critical first step is distinguishing between persistent symptoms and persistent urethritis 1. Symptoms alone without objective evidence are not sufficient grounds for retreatment. You must document:

• ≥5 polymorphonuclear leukocytes (PMNLs) per high-power field on urethral smear, OR
• Positive leukocyte esterase test on first-void urine, OR
• ≥10 WBCs per high-power field in first-void urine sediment 1

If these objective signs are absent, the patient likely has post-infectious symptoms or chronic prostatitis/chronic pelvic pain syndrome rather than active urethritis 1.

Understanding Ureaplasma's Role

Ureaplasma causes significantly less urethral inflammation than Chlamydia trachomatis or Mycoplasma genitalium 2. The research shows that while C. trachomatis strongly associates with microscopic NGU, Ureaplasma urealyticum only associates with severe NGU (>30 PMNLs/HPF), and U. parvum frequently colonizes patients with no or mild signs of inflammation 2. This means:

• A negative NAAT after treatment likely represents true cure
• Persistent mild symptoms may not indicate persistent infection
• Ureaplasma testing and treatment should only be considered after ruling out other STIs 2

Differential Diagnosis for Persistent Symptoms

If objective urethritis is confirmed, test for these more likely causes:

Primary Pathogens to Exclude:

1. Mycoplasma genitalium - Most important cause of persistent NGU after standard therapy 1, 3, 4

   • Responds better to azithromycin than doxycycline
   • Increasingly macrolide-resistant
   • NAAT testing strongly recommended if not done initially

2. Trichomonas vaginalis - Often missed cause 1, 5, 3

   • Culture or NAAT from urethral swab
   • Consider especially in populations where T. vaginalis prevalence >2% 3

3. Chlamydia trachomatis - Retest to exclude reinfection 1

4. Neisseria gonorrhoeae - Retest to exclude reinfection 1

Consider Reinfection vs. Treatment Failure:

Reinfection is more common than treatment failure 6. Evaluate:

• Was the partner treated?
• Has there been new sexual exposure?
• Was treatment compliance adequate?

Treatment Algorithm for Confirmed Persistent Urethritis

If Initial Treatment Was Doxycycline:

• Azithromycin 500 mg stat, then 250 mg daily for 4 days (preferred over 1g single dose due to M. genitalium resistance concerns) 3
• PLUS Metronidazole 400-500 mg twice daily for 5-7 days (covers T. vaginalis and anaerobes) 4

If Initial Treatment Was Azithromycin:

• Doxycycline 100 mg twice daily for 7 days
• PLUS Metronidazole 400-500 mg twice daily for 5-7 days 4
• OR Moxifloxacin 400 mg once daily for 7-14 days (if M. genitalium suspected/confirmed) 4, 7

Important Caveats:

• Do not retreat with the same regimen unless noncompliance or reinfection is documented 1, 5
• Avoid empiric azithromycin 1g as first-line without M. genitalium testing, as this drives macrolide resistance 3, 7
• Test-of-cure for M. genitalium should be performed ≥3 weeks after treatment start 4

When Symptoms Persist Without Objective Urethritis

If microscopy shows no inflammation but symptoms persist for >3 months, consider:

• Chronic prostatitis/chronic pelvic pain syndrome - Look for perineal, penile, or pelvic pain; irritative voiding symptoms; pain during/after ejaculation; new-onset premature ejaculation 1
• Post-infectious urethral syndrome - Symptoms without inflammation
• Non-infectious causes - Urologic evaluation may be warranted

The value of extending antimicrobial therapy in patients with persistent symptoms but no objective signs of urethritis has not been demonstrated 1.

Partner Management

Regardless of the specific etiology, all partners from the preceding 60 days must be evaluated and treated 1. Instruct the patient to abstain from sexual intercourse until both partners complete treatment and symptoms resolve 1.

Key Clinical Pitfalls to Avoid

1. Retreating based on symptoms alone without confirming objective urethritis
2. Assuming persistent Ureaplasma when the organism tests negative and causes minimal inflammation
3. Missing M. genitalium as the most common cause of persistent NGU
4. Ignoring reinfection as more likely than treatment failure
5. Using azithromycin 1g repeatedly without resistance testing, driving M. genitalium resistance
6. Testing too early - NAATs can remain positive <3 weeks after successful treatment due to dead organism DNA 6